Latest News & Articles

This first transplantation was performed in StemCells Inc.’s phase 1/2 clinical trial evaluating the safety and efficacy of purified human neural embryonic stem cells in a volunteer patient as a treatment for the dry form of age-related macular degeneration.

The United States Food and Drug Administration (FDA) concluded, by a vote of 17 to 2, that there is significant confidence that the Argus II Retinal Prosthesis system is safe for use.

For those who suffer from allergies, dry air and the explosive release of pollen from April to August trigger a full-scale attack on the eyes.

Diabetes mellitus — diabetic retinopathy remains the leading cause of blindness in the Western world. This article will focus primarily on diabetic retinopathy, which is by far the most common and most vision-threatening ocular disease affecting individuals with diabetes.

The U.S. Food and Drug Administration (FDA) has approved the new drug AFLIBERCEPT (EYLEA) for the treatment of macular edema following central retinal vein occlusion (CRVO). FDA Approves Eylea for Macular Oedema following CRVO.

REVOLUTION in glaucoma monitoring. Continuous intraocular pressure measurement with a wireless ocular sensor: the first clinical experience in patients with open-angle glaucoma.